Overactive Bladder

Efficacy and tolerability of propiverine hydrochloride extended-release compared with immediate-release in patients with neurogenic detrusor overactivity - Abstract

Published on Friday, 01 February 2013 16:29

Study design: Double-blind, randomised, multicentre study.

Effects of kinin B(1) and B(2) receptor antagonists on overactive urinary bladder syndrome induced by spinal cord injury in rats, "Beyond the Abstract," by Stefânia Forner, BSc, MSc, et al.

Published on Thursday, 31 January 2013 16:50

BERKELEY, CA (UroToday.com) - Spinal cord injury (SCI) is a devastating disease that affects about 2.5 million people worldwide; it has a profound impact on quality of life and life expectancy, causing a great economic burden to society.

Association of insulin resistance with overactive bladder in female patients - Abstract

Published on Thursday, 31 January 2013 12:01

PURPOSE: Metabolic syndrome and obesity have been advocated to be risk factors for the development of overactive bladder (OAB).

Randomised, multicentre, placebo-controlled, double-blind crossover study investigating the effect of solifenacin and oxybutynin in elderly people with mild cognitive impairment: The SENIOR study - Abstract

Published on Wednesday, 30 January 2013 18:46

BACKGROUND: Compared with younger people, the elderly are more likely to suffer from overactive bladder (OAB) and to have other chronic conditions that affect physical or cognitive function.

Urgency, detrusor overactivity and posterior vault prolapse in women who underwent pelvic organ prolapse repair - Abstract

Published on Tuesday, 29 January 2013 18:52

Introduction: We investigated the relationship between posterior vault prolapse and overactive bladder (OAB) symptoms or detrusor overactivity (DO) and their changes after surgical repair.

Safety of solifenacin and tolterodine in the treatment of overactive bladder: A meta-analysis - Abstract

Published on Monday, 28 January 2013 15:43

OBJECTIVE: To evaluate the safety of solifenacin and tolterodine in the treatment of overactive bladder (OAB).

Effects of herpes simplex virus vector-mediated enkephalin gene therapy on bladder overactivity and nociception - Abstract

Published on Friday, 25 January 2013 14:45

We previously reported the effects of herpes simplex virus (HSV) vector-mediated enkephalin on bladder overactivity and pain.

FDA approves over-the-counter Oxytrol for Women to treat overactive bladder

Published on Friday, 25 January 2013 09:37

SILVER SPRING, MD USA (Press Release) - January 25, 2013 - The U.S. Food and Drug Administration today approved Oxytrol for Women, the first over-the-counter treatment for overactive bladder in women ages 18 years and older.

BOTOX® (onabotulinumtoxinA) receives U.S. Food and Drug Administration approval for the treatment of overactive bladder for adults who have an inadequate response to or are intolerant of an anticholinergic medication

Published on Thursday, 24 January 2013 13:09

IRVINE, CA USA (Press Release) - (BUSINESS WIRE) -

BOTOX® Demonstrates Efficacy in Reducing Urinary Leakage Episodes

Neurogenic lower urinary tract dysfunction - Abstract

Published on Wednesday, 23 January 2013 16:44

The two roles of the lower urinary tract are storage of urine and emptying at appropriate times

Page 10 of 54